SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-023944
Filing Date
2024-06-14
Accepted
2024-06-14 17:30:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 468092
2 ex4-4.htm EX-4.4 397365
3 ex4-5.htm EX-4.5 429267
4 ex5-1.htm EX-5.1 54136
5 ex23-1.htm EX-23.1 5020
6 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 63020
7 forms-3_001.jpg GRAPHIC 4476
8 forms-3_002.jpg GRAPHIC 3708
9 ex5-1_001.jpg GRAPHIC 7504
  Complete submission text file 0001493152-24-023944.txt   1440177
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280244 | Film No.: 241046127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)